A double-blind, double dummy, phase IV, randomized, multicenter, parallel group, placebo controlled trial to evaluate the effect of rosuvastatin on triglycerides levels in Mexican hypertriglyceridemic patients.

Trial Profile

A double-blind, double dummy, phase IV, randomized, multicenter, parallel group, placebo controlled trial to evaluate the effect of rosuvastatin on triglycerides levels in Mexican hypertriglyceridemic patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2013

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Dec 2010 Actual end date changed from Dec 2008 to Feb 2009 as reported by ClinicalTrials.gov
    • 15 Dec 2010 Actual initiation date changed from Jun 2007 to Jan 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top